Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the acf domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/cr0ph/staging.phastar.com/wp-includes/functions.php on line 6260
FSP Strategic Partnerships for Drug Development
On-demand webinar thumbnail showing a hand touching a digital data screen

Implementing a Gold Standard FSP Strategic Partnership to Fuel Efficient Drug Development

1 minute read

Published: March 7th, 2024

Complete the form below to watch the webinar

Featuring:

  • Francis Kendall, Head of Oncology Statistical Programming, Biometrics, Oncology R&D, AstraZeneca
  • Alan Salter, Director, R&D Clinical Partner Management, Takeda
  • Ping-Chung Chang, Head Business Transformation, Phastar
  • Elisa Mansfield, Vice President, FSP, Phastar

Moderated by Natalie Fforde, Senior Vice President, Global Strategic Partnerships, Phastar

Related articles

Smarter Confidence Intervals in Multicenter Trials: The BSVI Advantage

Smarter Confidence Intervals in Multicenter Trials: The BSVI Advantage

October 12th, 2026 2 minute read

Confidence intervals are an important component of clinical trial reporting, supporting the accurate and reliable int...

Regulatory Expectations: Bayesian Guidance from the FDA, CDE, and EMA

Regulatory Expectations: Bayesian Guidance from the FDA, CDE, and EMA

September 28th, 2026 2 minute read

Bayesian methods are increasingly being considered to support dose optimization, extrapolation, and adaptive designs ...

AI for Clinical Research Series – Prediction

AI for Clinical Research Series – Prediction

June 26th, 2026 1 minute read

Augmenting Clinical Trials with Synthetic or Simulated Patients, Projecting Long-Term Benefit-Risk, and Developing Re...